Genetic Polymorphisms of Glutathione S-Transferase and Risk of Vitiligo in the Chinese Population

被引:30
|
作者
Liu, Ling [1 ]
Li, Chunying [1 ]
Gao, Jian [1 ]
Li, Kai [1 ]
Gao, Lin [1 ]
Gao, Tianwen [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China
关键词
OXIDATIVE DNA-DAMAGE; GENERALIZED VITILIGO; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; KOREAN POPULATION; ATOPIC-DERMATITIS; HERITABLE FACTORS; ACTIVE VITILIGO; SELENIUM LEVELS; GASTRIC-CANCER;
D O I
10.1038/jid.2009.143
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vitiligo is a common acquired depigmenting disorder characterized by white areas on the skin. Oxidative stress is a major pathogenesis hypothesis of vitiligo. Glutathione S-transferases (GSTs) are enzymes involved in protecting cells against chemical toxicity and stress. We hypothesized that the GSTM1- and GSTT1-null genotypes and GSTP1 polymorphisms were associated with increased risk for vitiligo. In a hospital-based case-control study of 749 vitiligo patients and 763 age-and sex-frequency-matched healthy controls, GSTM1 and GSTT1 genotypes and GSTP1 (Ile104Val, Ala113Val, Gly169Asp) polymorphisms were analyzed using the multiplex PCR and PCR-restriction fragment length polymorphism technique, respectively. We found that the GSTT1-null genotype was significantly associated with the susceptibility to vitiligo and the GSTM1-null genotype also showed a trend toward vitiligo association. We further analyzed the combined effect of GSTM1-null and GSTT1-null genotypes and showed an increased risk of developing vitiligo. By contrast, no statistically significant association was found between GSTP1 polymorphisms and vitiligo risk. These results suggest that individuals with homozygous deletion of GSTT1 and/or GSTM1 have a greater predisposition to vitiligo.
引用
收藏
页码:2646 / 2652
页数:7
相关论文
共 50 条
  • [31] Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer
    Jiao, Li
    Bondy, Melissa L.
    Hassan, Manal M.
    Chang, David Z.
    Abbruzzese, James L.
    Evans, Douglas B.
    Smolensky, Michael H.
    Li, Donghui
    CANCER, 2007, 109 (05) : 840 - 848
  • [32] Glutathione S-transferase gene polymorphisms and risk of nasal or colorectal polyposis
    Zhang, Yonglan
    Zhang, Haichao
    Lin, Peng
    Zhang, Guimin
    BIOSCIENCE REPORTS, 2019, 39
  • [33] Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population
    Matsuno, K
    Kubota, T
    Matsukura, Y
    Ishikawa, H
    Iga, T
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (05) : 560 - 562
  • [34] Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study
    Seow, A
    Yuan, JM
    Sun, CL
    Van den Berg, D
    Lee, HP
    Yu, MC
    CARCINOGENESIS, 2002, 23 (12) : 2055 - 2061
  • [35] Glutathione S-transferase M1 polymorphism and colorectal cancer risk in Chinese population
    Teng, Zan
    Wang, Lei
    Zhang, Jingdong
    Cai, Shuang
    Liu, Yunpeng
    TUMOR BIOLOGY, 2014, 35 (03) : 2117 - 2121
  • [36] Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver:: Consequences for enzyme expression and busulfan conjugation
    Bredschneider, M
    Klein, K
    Mürdter, TE
    Marx, C
    Eichelbaum, M
    Nüssler, AK
    Neuhaus, P
    Zanger, UM
    Schwab, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (06) : 479 - 487
  • [37] Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population
    Sun-Seog Kweon
    Min-Ho Shin
    Hee-Nam Kim
    Soo-Hyun Kim
    Ho-Cheol Kang
    Molecular Biology Reports, 2014, 41 : 3793 - 3799
  • [38] Association of genetic polymorphisms at the glutathione S-transferase Pi locus with prostate cancer
    Khabaz, Mohamad Nidal
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (05) : 846 - 850
  • [39] Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
    Peters, U
    Preisler-Adams, S
    Hebeisen, A
    Hahn, M
    Seifert, E
    Lanvers, C
    Heinecke, A
    Horst, J
    Jürgens, H
    Lamprecht-Dinnesen, A
    ANTI-CANCER DRUGS, 2000, 11 (08) : 639 - 643
  • [40] Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects
    Kuehne, A.
    Sezer, O.
    Heider, U.
    Meineke, I.
    Muhlke, S.
    Niere, W.
    Overbeck, T.
    Hohloch, K.
    Truemper, L.
    Brockmoeller, J.
    Kaiser, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (05) : 749 - 757